Imaging Mass Spectrometry Reveals the Changes in the Taurine Conjugates of Dihydroxycholanoic Acid During Hepatic Warm Ischemia and Reperfusion in a Rat Model

Transplant Proc. 2020 Jul-Aug;52(6):1880-1883. doi: 10.1016/j.transproceed.2020.01.169. Epub 2020 Jun 30.

Abstract

Warm ischemia and reperfusion injury (IRI) is a prognostic factor in donation after cardiac death donor transplantation. However, a reliable method to predict IRI before transplantation has not been established. The aim of this study was to identify predictive markers of hepatic IRI by simultaneous measurement of endogenous molecules using matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS). Rats were subjected to hepatic warm ischemia (70%) for 30 or 90 minutes and subsequent reperfusion. The livers were collected at the end of ischemia and 1 hour, 6 hours, and 24 hours after reperfusion. The liver tissue sections were applied to IMS (m/z 200-2000). Candidate molecules were identified by tandem mass spectrometry. Imaging mass spectrometry (IMS) revealed a significant increase in the taurine conjugates of dihydroxycholanoic acid (TDHCA) during ischemia and a tendency to return to the basal level after reperfusion. Notably, high-resolution measurements revealed focal accumulation of TDHCA in the intrahepatic bile duct with ischemic time. In conclusion, IMS is a useful method to detect minute changes provoked by ischemia, which are barely detectable in assays involving homogenization. Accordingly, focal accumulation of TDHCA during ischemia may be a candidate marker for predicting later IRI.

MeSH terms

  • Animals
  • Deoxycholic Acid / analysis*
  • Disease Models, Animal
  • Liver* / chemistry
  • Male
  • Rats
  • Reperfusion Injury*
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods*
  • Taurine / analysis
  • Warm Ischemia / adverse effects*

Substances

  • Deoxycholic Acid
  • Taurine